Pascal Soriot

Pascal Soriot is currently Chief Executive Officer & Executive Director at AstraZeneca PLC since 2012, Chief Executive Officer at AstraZeneca Pharmaceuticals LP, Chief Executive Officer & Director at AstraZeneca UK Ltd. since 2012, Chief Executive Officer & Executive Director at AstraZeneca Holding GmbH, Chief Executive Officer at AstraZeneca Österreich GmbH, Chief Executive Officer & Director at AstraZeneca Colombia SAS since 2012, Chairman at AstraZeneca AB, Director at The Sustainable Markets Initiative since 2023, Director at Agilent Technologies, Inc. starting 2025, Director at Pharmaceutical Research & Manufacturers of America, and Director at Acerta Pharma BV.
Former roles include Director & Chief Executive Officer-Roche Group at Genentech, Inc. in 2012, Independent Non-Executive Director at CSL Ltd. from 2020 to 2021, Director at Chugai Pharmaceutical Co., Ltd. from 2010 to 2011, Independent Director at Viela Bio, Inc. from 2019 to 2020, Chief Operating Officer at Roche Pharmaceuticals, Inc. from 2010 to 2012, Chief Operating Officer at Sanofi-Aventis U.S.
LLC in 2006, Vice President-Asia Pacific at Hoechst Marion Rousel JP in 2000, and Manager-District Sales at Roussel NZ Ltd. in 1989.
Education includes an MBA from École des Hautes Études Commerciales de Paris and a doctorate from École Nationale Vétérinaire d'Alfort.